Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu)
Conclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3.
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/crie/9514578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832576758393602048 |
|---|---|
| author | Ai Chida Yutaka Hasegawa Toshie Segawa Daisuke Yamabe Hirotaka Yan Yusuke Chiba Hiraku Chiba Hirofumi Kinno Tomoyasu Oda Yoshihiko Takahashi Koji Nata Yasushi Ishigaki |
| author_facet | Ai Chida Yutaka Hasegawa Toshie Segawa Daisuke Yamabe Hirotaka Yan Yusuke Chiba Hiraku Chiba Hirofumi Kinno Tomoyasu Oda Yoshihiko Takahashi Koji Nata Yasushi Ishigaki |
| author_sort | Ai Chida |
| collection | DOAJ |
| description | Conclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3. |
| format | Article |
| id | doaj-art-5e502893f22c4b439af62c5bc4e39bfe |
| institution | Kabale University |
| issn | 2090-651X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Endocrinology |
| spelling | doaj-art-5e502893f22c4b439af62c5bc4e39bfe2025-01-31T00:00:02ZengWileyCase Reports in Endocrinology2090-651X2025-01-01202510.1155/crie/9514578Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu)Ai Chida0Yutaka Hasegawa1Toshie Segawa2Daisuke Yamabe3Hirotaka Yan4Yusuke Chiba5Hiraku Chiba6Hirofumi Kinno7Tomoyasu Oda8Yoshihiko Takahashi9Koji Nata10Yasushi Ishigaki11Division of Diabetes, Metabolism and EndocrinologyDivision of Diabetes, Metabolism and EndocrinologyDivision of Diabetes, Metabolism and EndocrinologyDepartment of Orthopaedic SurgeryDepartment of Orthopaedic SurgeryDepartment of Orthopaedic SurgeryDivision of Diabetes, Metabolism and EndocrinologyDivision of Diabetes, Metabolism and EndocrinologyDivision of Diabetes, Metabolism and EndocrinologyDivision of Diabetes, Metabolism and EndocrinologyDivision of Medical BiochemistryDivision of Diabetes, Metabolism and EndocrinologyConclusion: Evocalcet may be a promising therapeutic candidate for symptomatic FHH3.http://dx.doi.org/10.1155/crie/9514578 |
| spellingShingle | Ai Chida Yutaka Hasegawa Toshie Segawa Daisuke Yamabe Hirotaka Yan Yusuke Chiba Hiraku Chiba Hirofumi Kinno Tomoyasu Oda Yoshihiko Takahashi Koji Nata Yasushi Ishigaki Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) Case Reports in Endocrinology |
| title | Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) |
| title_full | Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) |
| title_fullStr | Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) |
| title_full_unstemmed | Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) |
| title_short | Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu) |
| title_sort | successful treatment with evocalcet against familial hypocalciuric hypercalcemia type 3 fhh3 identified by ap2s1 gene mutation p arg15leu |
| url | http://dx.doi.org/10.1155/crie/9514578 |
| work_keys_str_mv | AT aichida successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT yutakahasegawa successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT toshiesegawa successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT daisukeyamabe successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT hirotakayan successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT yusukechiba successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT hirakuchiba successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT hirofumikinno successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT tomoyasuoda successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT yoshihikotakahashi successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT kojinata successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu AT yasushiishigaki successfultreatmentwithevocalcetagainstfamilialhypocalciurichypercalcemiatype3fhh3identifiedbyap2s1genemutationparg15leu |